Mei Pharma Inc (NASDAQ:MEIP) showed a decrease of 4.45% in shares shorted. In April was issued MEIP’s total 334,900 shares shorted by FINRA. The down change of 4.45% from 350,500 shares was reported. 2 days will cost MEIP with 209,200 average volume to recover its former position.

The stock decreased 0.62% or $0.02 during the last trading session, touching $3.18.MEI Pharma, Inc. has volume of 131,543 shares. Since April 7, 2018 MEIP has risen 42.73% and is uptrending. The stock outperformed the S&P 500 by 38.36%.

MEI Pharma, Inc., an oncology company, focuses on the clinical development of drugs for the treatment of cancer.The company has $226.25 million market cap. The companyÂ’s clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.Currently it has negative earnings. The Company’s clinical development portfolio also includes ME-401, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia or follicular lymphoma; and ME-344, an isoflavone-derived mitochondrial inhibitor for the treatment of HER2-negative breast cancer.

MEI Pharma, Inc. (NASDAQ:MEIP) Ratings Coverage

A total of 2 analysts rate MEI Pharma (NASDAQ:MEIP) as follows: 2 “Buy”, 0 “Hold” and 0 “Sell”. Тherefore 100% are bullish. (NASDAQ:MEIP) has 7 ratings reports on Apr 7, 2019 according to StockzIntelligence. The company rating was initiated by Oppenheimer on Wednesday, February 27. On Thursday, March 21 the firm has “Buy” rating given by H.C. Wainwright.

For more MEI Pharma, Inc. (NASDAQ:MEIP) news announced briefly go to: Seekingalpha.com, Seekingalpha.com, Prnewswire.com, Nasdaq.com or Benzinga.com. The titles are as follows: “Constellation Pharmaceuticals: A Recent IPO Of Interest – Seeking Alpha” announced on August 20, 2018, “MEI Pharma: A Rare Hidden Gem With Impressive Clinical Data – Seeking Alpha” on January 21, 2015, “MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress – PR Newswire” with a publish date: June 15, 2018, “Should You Buy MEI Pharma (MEIP) Ahead of Earnings? – Nasdaq” and the last “The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines (June 3-9) – Benzinga” with publication date: June 03, 2018.